US Prescription Drug User Fee Act (PDUFA): An Introduction for the Pharmaceutical Physician.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 1, p. 7, doi. 10.1007/s40290-016-0170-6
- By:
- Publication type:
- Article
Works matching IS 11782595 AND DT 2017 AND VI 31 AND IP 1
Results: 8
1
2
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 1, p. 69, doi. 10.1007/s40290-016-0171-5
- Publication type:
- Article
3
The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 1, p. 21, doi. 10.1007/s40290-016-0172-4
- By:
- Publication type:
- Article
4
Assessment of a Severity-Based Algorithm to Detect Signals of Severe Drug-Induced Liver Injury Using Spontaneous Reporting Database.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 1, p. 41, doi. 10.1007/s40290-016-0173-3
- By:
- Publication type:
- Article
5
Factors that Motivate Healthcare Professionals to Report Adverse Drug Events: A Systematic Review.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 1, p. 13, doi. 10.1007/s40290-016-0174-2
- By:
- Publication type:
- Article
6
Forum.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 1, p. 53, doi. 10.1007/s40290-016-0175-1
- Publication type:
- Article
7
Characterization of the Recent Postmarketing Safety Measures in Europe Focusing on Additional Pharmacovigilance Activities.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 1, p. 31, doi. 10.1007/s40290-016-0177-z
- By:
- Publication type:
- Article
8
Pharmacovigilance: Work in Progress.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 1, p. 1, doi. 10.1007/s40290-016-0169-z
- By:
- Publication type:
- Article